Companies in the Cardiovascular disease industry
Cardiovascular diseaseName | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Abbott is an Illinois-based laboratory supply and pharmaceutical company founded in 1944 by Wallace Calvin Abbott. | ||||||
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity. | ||||||
Spire is a company developing tags that provide health tracking including respiration, sleep, stress, activity, and pulse rate. | ||||||
miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health. | ||||||
Eko Health is a digital health and AI technology company developing tools for heart and lung disease detection. | ||||||
Verily is developing tools and platforms to enable more continuous health data collection for timely decision-making and effective interventions. They are running longitudinal studies to better understand ways to predict and prevent disease onset and progression. | ||||||
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs. | ||||||
CVS Health is a Woonsocket, Rhode Island-based company founded in 1963. | ||||||
Verve Therapeutics is a company in Cambridge, Massachusetts. | ||||||
A biopharmaceutical company developing therapeutics for treating age-related diseases. | ||||||
Perceiv AI is a Canada-based precision medicine technology company founded in 2018, headquartered in Montreal Innovation District and founded by Christian L Dansereau. It is a company that is committed to improving the way treatments are done using a refined patient selection. | ||||||
A company that developed Barostim neo, an implantable technology to treat high blood pressure and heart failure | ||||||
AliveCor is a San Francisco-based company developing AI-based ECG technologies. | ||||||
Moving Analytics is developing a virtual care management software for cardiac rehab. | ||||||
My mhealth is a telemedicine company based in Bournemouth. It specialises in digital health apps for the management of longterm conditions such as diabetes, COPD and heart disease where patients use anticoagulation therapy. | ||||||
Cytokinetics is a small Molecules founded in 1998. | ||||||
By applying the latest research in Artificial intelligence, Cardiologs provides a web solution to streamline this process at large scale, enabling the highest diagnostic yield, for the least physician effort. | ||||||
MyoKardia is a company developing targeted therapies for cardiocavscular diseases founded in 2012 by Leslie Leinwand. | ||||||
Hello Heart is a company founded in 2013 by Ziv Meltzer. | ||||||
A cardiovascular genomic diagnostics company that provides clinicians information to improve patient care | ||||||
NeuroTronik is a company that develops neurostimulation therapeutic devices which are designed to treat acute heart failure syndrome. | ||||||
Milestone Pharmaceuticals is a small Molecules founded in 2007. | ||||||
Implicity developed a universal remote monitoring platform for cardiac patients with connected pacemakers and implantable defibrillators. | ||||||
Heartbeat is an experience created to screen, diagnose, track and manage cardiovascular risk and disease to keep you at your healthiest. | ||||||
Ultromics is an artificial Intelligence company founded in 2017 by Paul Leeson. |
